We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
AUM
$78.9M
AUM Growth
-$8.45M
Cap. Flow
-$8.23M
Cap. Flow %
-10.43%
Top 10 Hldgs %
39.35%
Holding
803
New
189
Increased
92
Reduced
66
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 26.37%
2 Technology 14.3%
3 Industrials 13.87%
4 Consumer Discretionary 7.56%
5 Materials 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSEM icon
226
CALL
Tower Semiconductor
TSEM
$28.2B
$23K 0.03%
+621
New +$25.7K
PD icon
227
PagerDuty
PD
$915M
$22K 0.03%
+1,000
New +$27.8K
PNNT
228
Pennant Park Investment Corp
PNNT
$244M
$22K 0.03%
3,800
CERO
229
DELISTED
CERo Therapeutics
CERO
$22K 0.03%
+1
New +$21.7K
ADP icon
230
Automatic Data Processing
ADP
$108B
$21K 0.03%
100
ALL icon
231
Allstate
ALL
$66.3B
$21K 0.03%
200
+51
+34% +$5.79K
ASTL icon
232
Algoma Steel
ASTL
$467M
$21K 0.03%
3,085
B
233
Barrick Mining
B
$67.2B
$21K 0.03%
1,250
-350
-22% -$6.38K
KINS icon
234
Kingstone Companies
KINS
$276M
$21K 0.03%
17,063
+63
+0.4% +$82
NAC icon
235
Nuveen California Quality Municipal Income Fund
NAC
$1.85B
$21K 0.03%
2,000
INCY icon
236
CALL
Incyte
INCY
$24.5B
$20K 0.03%
+327
New +$21.9K
MS.PRE icon
237
Morgan Stanley Series E Preferred Stock
MS.PRE
$879M
$20K 0.03%
+800
New +$20.4K
NAD icon
238
Nuveen Quality Municipal Income Fund
NAD
$2.75B
$20K 0.03%
1,800
PDO
239
PIMCO Dynamic Income Opportunities Fund
PDO
$1.87B
$20K 0.03%
1,600
ACCD
240
DELISTED
Accolade Inc
ACCD
$20K 0.03%
+1,500
New +$19.5K
PSTX
241
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$20K 0.03%
11,500
+1,500
+15% +$3.83K
ATEC icon
242
Alphatec Holdings
ATEC
$1.45B
$19K 0.02%
+1,100
New +$17.1K
GTLB icon
243
GitLab
GTLB
$7.11B
$19K 0.02%
+380
New +$14.1K
JPC icon
244
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
$19K 0.02%
3,000
SCD
245
LMP Capital and Income Fund
SCD
$360M
$19K 0.02%
1,500
CHRW icon
246
C.H. Robinson
CHRW
$17B
$18K 0.02%
200
CTXR icon
247
Citius Pharmaceuticals
CTXR
$19.8M
$18K 0.02%
+600
New +$19.7K
HKIT icon
248
Hitek Global
HKIT
$28.1M
$18K 0.02%
+1
New +$26.6K
MSFT icon
249
Microsoft
MSFT
$3.74T
$18K 0.02%
+55
New +$17.2K
NJR icon
250
New Jersey Resources
NJR
$5.55B
$18K 0.02%
400

Similar funds

FNY Investment Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, FNY Investment Advisers held 803 positions worth $78.9M, down 9.7% from $87.4M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

FNY Investment Advisers withdrew a net $8.23M in Q2 2023, closing 232 positions and reducing 66 holdings. Its most notable exit was Oak Street Health, Inc., an estimated $8.19M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

Against the trend, FNY Investment Advisers opened a new position in IVERIC bio, Inc. Common Stock worth $7.08M.

  • FNY Investment Advisers's largest Q2 2023 buy was IVERIC bio, Inc. Common Stock: 180,106 shares worth $7.08M.
  • FNY Investment Advisers added most to Univar Solutions Inc. in Q2 2023, an estimated $1.85M increase.
  • FNY Investment Advisers's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $1.53M.
  • FNY Investment Advisers fully exited Oak Street Health, Inc. in Q2 2023, selling an estimated $8.19M.
  • FNY Investment Advisers's ten largest holdings make up 39% of its $78.9M portfolio in Q2 2023.
  • FNY Investment Advisers opened 189 new positions and closed 232 in Q2 2023.
  • FNY Investment Advisers's portfolio value fell 9.7% quarter-over-quarter to $78.9M.

Based on FNY Investment Advisers's 13F filing for Q2 2023, filed 11 Jul 2023.